Adherence to Surveillance Guidelines in Nondysplastic Barrett's Esophagus

被引:5
|
作者
Dalal, Kunal S. [1 ]
Coffing, Jessica [2 ]
Imperiale, Thomas F. [1 ]
机构
[1] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA
[2] Richard L Roudebush VA Med Ctr, Ctr Innovat Hlth Serv Res & Dev, Indianapolis, IN USA
关键词
Barrett's esophagus; nondysplastic Barrett's; Barrett's surveillance; MEDICAL POSITION STATEMENT; PRACTICE PATTERNS; ENDOSCOPIC SURVEILLANCE; PREMALIGNANT CONDITIONS; UPDATED GUIDELINES; MANAGEMENT; DIAGNOSIS; GASTROENTEROLOGISTS; ADENOCARCINOMA; REGISTRY;
D O I
10.1097/MCG.0000000000000777
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Surveillance patterns in Barrett's esophagus (BE) are not well characterized. Guidelines published between 2002 and 2008 recommended surveillance esophagogastroduodenoscopy (sEGD) at 3-year intervals for nondysplastic BE (NDBE). We assessed guideline adherence in incident NDBE in a Veterans Affairs (VA)-based study. Methods: At a single VA center, we identified incident cases of biopsy-confirmed NDBE between January, 2006 and December, 2008. We excluded patients aged 76 years and above and those who developed BE-associated dysplasia or cancer during follow-up. All sEGDs through October, 2014 were documented. Our primary criteria classified cases as guideline adherent if a sEGD was performed within 6 months of each expected 3-year surveillance interval; in cases with 2 sEGDs, 1 sEGD >6 months, and 1 year outside an interval was allowed if the average interval was between 2.5 and 3.5 years. Comorbidity, primary care encounters, presence of long-segment BE (LSBE), endoscopist recommendations, and Charlson comorbidity index (CCI) were assessed. Results: We identified 110 patients (96.4% male, 93.6% white) with mean age 58.98.5 years at index EGD. Median follow-up was 6.7 years (range, 3.7 to 8.6). Thirty-three (30.0%) cases were guideline adherent; 77 (70.0%) cases were nonadherent, including 52 (47.3%) with irregular surveillance and 25 (22.7%) with no surveillance. Forty cases (14 adherent) had 1 sEGD, 36 (18 adherent) had 2, 8 (1 adherent) had 3, and 1 nonadherent case had 4. Adherent cases were significantly older (61.5 vs. 57.9 y, P = 0.04), and tended to have more LSBE (33.3% vs. 20.8%, P = 0.16). There were no differences between adherent and nonadherent cases in annual primary care encounters (72.7% vs. 66.2%, P = 0.66), CCI >= 4 (15.2% vs. 15.6%, P = 0.95), biopsy-positive sEGDs (75.8% vs. 76.6%, P = 0.92), and any recommendation for subsequent surveillance (81.8% vs. 77.9%, P = 0.65). A logistic regression model using age, CCI, and LSBE showed an independent association between adherence and older age (P = 0.03). Conclusions: In a single-center VA cohort, sEGD of NDBE was mostly nonadherent to guidelines. Adherent cases were older at baseline with a trend toward more LSBE. A larger study is needed to identify medical and social factors associated with adherence or nonadherence to surveillance.
引用
收藏
页码:217 / 222
页数:6
相关论文
共 50 条
  • [1] Quantifying Adherence to Surveillance Guidelines in Nondysplastic Barrett's Esophagus
    Dalal, Kunal
    Coffing, Jessica
    Imperiale, Thomas F.
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB501 - AB501
  • [2] Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus
    Tavakkoli, Anna
    Appelman, Henry D.
    Beer, David G.
    Madiyal, Chaitra
    Khodadost, Maryam
    Nofz, Kimberly
    Metko, Val
    Elta, Grace
    Wang, Thomas
    Rubenstein, Joel H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 862 - +
  • [3] Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study
    Crockett, Seth D.
    Lipkus, Isaac M.
    Bright, Stephanie D.
    Sampliner, Richard E.
    Wang, Kenneth K.
    Boolchand, Vikram
    Lutzke, Lori S.
    Shaheen, Nicholas J.
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (01) : 23 - U59
  • [4] ADHERENCE TO GUIDELINES FOR SURVEILLANCE AND CHEMOPREVENTION OF NON-DYSPLASTIC BARRETT'S ESOPHAGUS
    Khan, Tanya
    Kraft, Cary
    Leet, Donna
    Libuit, Erin
    Xu, Chelsea
    Dalal, Nicole
    Pierce, Logan
    Ravi, Akshay
    Ko, Myung S.
    Kathpalia, Priya
    GASTROENTEROLOGY, 2023, 164 (06) : S514 - S515
  • [5] Adherence to clinical guidelines for Barrett's esophagus
    Holmberg, Dag
    Ness-Jensen, Eivind
    Mattsson, Fredrik
    Lagergren, Jesper
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (08) : 945 - 952
  • [6] The case for ablating nondysplastic Barrett's esophagus
    Ganz, Robert A.
    Mitlyng, Benjamin
    Leon, Sam
    GASTROINTESTINAL ENDOSCOPY, 2014, 80 (05) : 866 - 872
  • [7] Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States
    Abrams, Julian A.
    Kapel, Robert C.
    Lindberg, Guy M.
    Saboorian, Mohammad H.
    Genta, Robert M.
    Neugut, Alfred I.
    Lightdale, Charles J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (07) : 736 - 742
  • [8] Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis
    Westerveld, Donevan
    Khullar, Vikas
    Mramba, Lazarus
    Ayoub, Fares
    Brar, Tony
    Agarwal, Mitali
    Forde, Justin
    Chakraborty, Joydeep
    Riverso, Michael
    Perbtani, Yaseen B.
    Gupte, Anand
    Forsmark, Chris E.
    Draganov, Peter
    Yang, Dennis
    ENDOSCOPY INTERNATIONAL OPEN, 2018, 6 (03) : E300 - E307
  • [9] Adherence to Barrett's Esophagus Surveillance Guidelines in Relation to Prague Criteria and Seattle Protocol
    Tran, Phi P.
    Ancha, Anupama
    Emery, Alexis
    Halila, Kasey
    Tjahja, Matthew
    Shell, Mark
    Naumann, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S350 - S351
  • [10] Adherence to Guidelines in the Management of Barrett's Esophagus in the UK
    Troppmann, M.
    Endlicher, E.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (07): : 694 - 696